1-4 of 4
Stephanie Gregory
Close
Sort by
Journal Articles

A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era

Brief Report
Andrew M. Evens, Irene Helenowski, Erika Ramsdale, Chadi Nabhan, Reem Karmali, Britt Hanson, Benjamin Parsons, Scott Smith, Annette Larsen, June M. McKoy, Borko Jovanovic, Stephanie Gregory, Leo I. Gordon, Sonali M. Smith
Journal: Blood
Blood (2012) 119 (3): 692–695.
https://doi.org/10.1182/blood-2011-09-378414
Published: 2012
Includes: Supplemental data
Journal Articles

Update on a Prospective Study Evaluating the Safety and Efficacy of Combination Therapy with Fludarabine, Mitoxantrone and Rituximab Followed by Yttrium-90 Ibritumomab Tiuxetan and Maintenance Rituximab as Front Line Therapy for Patients with Indolent Lymphomas

Reem Karmali, MD, Mohamad Kassar, MD, Antonio M. Jimenez, MD, Parameswaran Venugopal, MD, Jamile M. Shammo, MD, Henry C. Fung, FRCP, MD, Robert Bayer, MD, Teresa O'Brien, Stephanie Gregory, MD
Journal: Blood
Blood (2010) 116 (21): 3946.
https://doi.org/10.1182/blood.V116.21.3946.3946
Published: 2010
Journal Articles

In Vivo Expansion of Megakaryocyte Progenitors in CD26 −/ − Mice: Implications for Novel Post-Transplant Therapeutics.

Shannon Kidd, Carlos E. Bueso-Ramos, MD, Laura A. Paganessi, Henry Fung, MD, Stephanie Gregory, MD, Kent W. Christopherson, PhD
Journal: Blood
Blood (2007) 110 (11): 1188.
https://doi.org/10.1182/blood.V110.11.1188.1188
Published: 2007
Journal Articles

Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone

Azra Raza, Huma Qawi, Laurie Lisak, Tanja Andric, Saleem Dar, Colleen Andrews, Paramesuaran Venugopal, Sefer Gezer, Stephanie Gregory, Jerome Loew, Erwin Robin, Shelby Rifkin, Wei-Tong Hsu, Ray-Win Huang
Journal: Blood
Blood (2000) 95 (5): 1580–1587.
https://doi.org/10.1182/blood.V95.5.1580.005k45_1580_1587
Published: 2000